Device Week, April 5, 2019 – A Trio Of FDA Guidance Docs To Keep An Eye On

In this week’s podcast, Medtech Insight journalists Shawn M. Schmitt, Ferdous Al-Faruque and Elizabeth Orr discuss a recent flurry of guidance document news from US FDA on facility inspections, artificial intelligence and anthrax detection devices. Medtech Insight articles addressing topics discussed in this episode: • With Fresh Guidance, US FDA Aims For Consistency In Device Facility Inspections (https://protect-us.mimecast.com/s/fbN6CQWNOwhkRVZoLsPtuEU?domain=medtech.pharmaintelligence.informa.com) • Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming (https://protect-us.mimecast.com/s/BJD-CR6MLxfvOYZ5XTPiIw3?domain=medtech.pharmaintelligence.informa.com) • After Years Of Waiting, FDA Classifies Anthrax Detection Devices As Class II (https://protect-us.mimecast.com/s/cBW0CVO5NBcxZBQg8sJEbEK?domain=medtech.pharmaintelligence.informa.com)